Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-26-009090
Filing Date
2026-03-19
Accepted
2026-03-19 17:00:41
Documents
111
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20251231_10k.htm   iXBRL 10-K 3164381
2 EXHIBIT 4.1 ex_932889.htm EX-4.1 16622
3 EXHIBIT 10.45 ex_932869.htm EX-10.45 291020
4 EXHIBIT 10.48 ex_934966.htm EX-10.48 60822
5 EXHIBIT 10.49 ex_934973.htm EX-10.49 10917
6 EXHIBIT 19 ex_932890.htm EX-19 98367
7 EXHIBIT 21 ex_931911.htm EX-21 1486
8 EXHIBIT 23.1 ex_931912.htm EX-23.1 6011
9 EXHIBIT 23.2 ex_932888.htm EX-23.2 4723
10 EXHIBIT 31.1 ex_931913.htm EX-31.1 8571
11 EXHIBIT 31.2 ex_931914.htm EX-31.2 8791
12 EXHIBIT 32.1 ex_931915.htm EX-32.1 4674
13 EXHIBIT 32.2 ex_931916.htm EX-32.2 4364
19 bar01.jpg GRAPHIC 37444
20 bar02.jpg GRAPHIC 37683
21 novalogosm.jpg GRAPHIC 14118
22 nvblogo.jpg GRAPHIC 16762
  Complete submission text file 0001437749-26-009090.txt   16323409

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA nby-20251231.xsd EX-101.SCH 116046
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20251231_def.xml EX-101.DEF 860450
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20251231_lab.xml EX-101.LAB 620688
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20251231_pre.xml EX-101.PRE 905478
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20251231_cal.xml EX-101.CAL 57529
115 EXTRACTED XBRL INSTANCE DOCUMENT nby20251231_10k_htm.xml XML 3073041
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 26775050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)